Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Yasser W. Al-Mula Abed"'
Autor:
Saif A. Khan, Dawood Al-Riyami, Yasser W. Al-Mula Abed, Saja Mohammed, Marwa Al-Riyami, Nabil M. Al-Lawati
Publikováno v:
Sultan Qaboos University Medical Journal, Vol 16, Iss 3, Pp 371-374 (2016)
Antibody-mediated rejection (ABMR) jeopardises short- and long-term transplant survival and remains a challenge in the field of organ transplantation. We report the first use of the anticomplement agent eculizumab in Oman in the treatment of a 61-yea
Externí odkaz:
https://doaj.org/article/9b1b29e7c7274c158d4fca19debfeb19
Autor:
Rana S. Hamid, Anupam K. Kakaria, Saif A. Khan, Saja Mohammed, Rashid Al-Sukaiti, Dawood Al-Riyami, Yasser W. Al-Mula Abed
Publikováno v:
Sultan Qaboos University Medical Journal, Vol 15, Iss 4, Pp 501-506 (2015)
Objectives: This study aimed to assess the technical success, safety and immediate and delayed complications of double-lumen tunnelled cuffed central venous catheters (TVCs) at the Sultan Qaboos University Hospital (SQUH), Muscat, Oman. Methods: This
Externí odkaz:
https://doaj.org/article/41c7e7f665f147fca20c08c15dfddd05
Publikováno v:
Journal of Medical Cases. 6:399-402
Autor:
Yasser W. Al-Mula Abed
Publikováno v:
Qatar Medical Journal
We describe an elderly gentleman with end stage renal disease on haemodialysis who presented with ophthalmic zoster infection and was discharged on oral acyclovir. He presented again a few days later with confusion and expressive dysphasia. Different
Publikováno v:
Oman Medical Journal. 29
Renal graft thrombosis is a serious and devastating complication of renal transplant that ultimately results in graft loss. It is associated with acute and hyper-acute rejections; however, the underlying cause in large proportion of patients remains
Autor:
Marwa Al-Riyami, Saif A. Khan, Saja Mohammed, Dawood Al-Riyami, Nabil M. Al-Lawati, Yasser W. Al-Mula Abed
Publikováno v:
Sultan Qaboos University Medical Journal, Vol 16, Iss 3, Pp 371-374 (2016)
Antibody-mediated rejection (ABMR) jeopardises short- and long-term transplant survival and remains a challenge in the field of organ transplantation. We report the first use of the anticomplement agent eculizumab in Oman in the treatment of a 61-yea